Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sleep and glycemic control in type 1 diabetes.
Barone MT, Wey D, Schorr F, Franco DR, Carra MK, Lorenzi Filho G, Menna-Barreto L. Barone MT, et al. Among authors: carra mk. Arch Endocrinol Metab. 2015 Feb;59(1):71-8. doi: 10.1590/2359-3997000000013. Arch Endocrinol Metab. 2015. PMID: 25926118
Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO).
Halpern B, Mancini MC, de Melo ME, Lamounier RN, Moreira RO, Carra MK, Kyle TK, Cercato C, Boguszewski CL. Halpern B, et al. Among authors: carra mk. Arch Endocrinol Metab. 2022 Apr 28;66(2):139-151. doi: 10.20945/2359-3997000000465. Epub 2022 Apr 11. Arch Endocrinol Metab. 2022. PMID: 35420271 Free PMC article.
The new obesity classification based on weight history is not proposed as a guideline.
Halpern B, Mancini MC, de Melo ME, Lamounier RN, Moreira RO, Carra MK, Cercato C, Boguszewski CL. Halpern B, et al. Among authors: carra mk. Arch Endocrinol Metab. 2022 Nov 17;66(6):936-937. doi: 10.20945/2359-3997000000571. Arch Endocrinol Metab. 2022. PMID: 36394490 Free PMC article. No abstract available.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
Preti RC, Ramirez LM, Monteiro ML, Carra MK, Pelayes DE, Takahashi WY. Preti RC, et al. Among authors: carra mk. Br J Ophthalmol. 2013 Jul;97(7):885-9. doi: 10.1136/bjophthalmol-2012-302675. Epub 2013 May 17. Br J Ophthalmol. 2013. PMID: 23686001 Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.